Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
OVERLAP
65%
OVERLAP
BY WEIGHT
24
# OF OVERLAPPING
HOLDINGS
EXV4.DE
60
HOLDINGS
53%
ALSO IN XSDR.DE
XSDR.DE
29
HOLDINGS
89%
ALSO IN EXV4.DE
SECTOR DRIFT (EXV4.DE minus XSDR.DE)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in EXV4.DE |
Weight in XSDR.DE |
Overlap | |
|---|---|---|---|---|
| ASTRAZENECA PLC | 13.8% | 17.7% | 13.8% | |
| NOVARTIS AG | 13.7% | 16.5% | 13.7% | |
| NOVO NORDISK A/S-B | 9.3% | 11.1% | 9.3% | |
| SANOFI-AVENTIS | 5.2% | 6.4% | 5.2% | |
| ESSILOR INTERNATIONAL | 4.9% | 6.0% | 4.9% | |
EXV4.DE Overweight Relative to XSDR.DE
| ROCHE HOLDING AG-BR | 14.3% | |
| GSK PLC | 4.9% | |
| BAYER AG | 2.4% | |
| SANDOZ GROUP AG | 1.7% | |
| FRESENIUS SE | 1.1% | |
| KONINKLIIJKE ELECTRONICS NV | 1.1% | |
| NOVOZYMES A/S-B SHARES | 1.1% | |
| MERCK KGAA | 0.9% | |
| SIEMENS HEALTHINEERS AG | 0.8% | |
| SMITH & NEPHEW PLC | 0.7% |
EXV4.DE Underweight Relative to XSDR.DE
| ROCHE HOLDING AG-GENUSSCHEIN | -18.4% | |
| ROCHE HOLDING LTD | -18.4% | |
| NOVARTIS AG-REG | -16.5% | |
| ASTRAZENECA PLC | -3.9% | |
| NOVARTIS AG | -2.8% | |
| NOVO NORDISK A/S-B | -1.8% | |
| SANOFI-AVENTIS | -1.2% | |
| ESSILOR INTERNATIONAL | -1.1% | |
| LONZA GROUP AG-REG | -0.6% | |
| ARGEN-X SE | -0.5% |